Baruk H, Melzer R, Vezous A, Farjeat J (1950) L'effondrement oestrogénique dans la démence precoce. Etude par la méthode des frottis vaginaux de Papanicolaou. Ann of Medical Psychol (Paris) 108:181–187
Google Scholar
Bédard P, Langelier P, Villeneuve A (1977) Estrogens and the Extrapyramidal System. Lancet II:1367–1368
Article
Google Scholar
Bédard P, Boucher R, Daigle M, DiPaolo T (1984) Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys. Psychoneuroendocrinology 9:375–379
Article
PubMed
Google Scholar
Beumont PJ, Gelder MG, Friesen HG, Harris GW, McKinnon PC, Mandelbrote BM, Wiles DH (1974) The effects of phenothiazines on endocrine function: Patients with inappropriaqte lactation and amenorrhea. Br J Psychiatry 124:413–419
PubMed
Google Scholar
Bleuler M (1943) Die spätschizophrenen Krankheitsbilder. Neurologie XV, 9:259–290
Google Scholar
Brambilla F, Guerrini A, Guastalla A, Rovere C, Riggi F (1975) Neuroendocrine Effect of Haloperidol Therapy in Chronic Schizophrenia. Psychopharmacologia 44:17–22
Article
PubMed
Google Scholar
Brambilla F (1980) Neuroendocrine function in schizophrenia. Acta Psychiatria Belg 80:421
Google Scholar
Carlsson A (1987) The dopamine hypothesis of schizophrenia 20 years later. In: Häfner H; Gattaz WF; and Janzarik W (eds) Search for the causes of schizophrenia. Springer, Berlin Heidelberg New York, pp 223–235
Google Scholar
Chang SS, Renshaw DC (1986) Psychosis and pregnancy. Compr Ther 12:36–41
Google Scholar
Collu R, Jequier JC, Leboeuf J, Ducharme JR (1977) Endocrine effects of pimozide, a specific dopaminergic blocker. J Endocrinol Metab 44:981–948
Google Scholar
Cookson JC (1981) Oestrogens, dopamine and mood. Br J Psychiatry 139:365
PubMed
Google Scholar
Czernik A, Kleesiek K (1979) Die Wirkung von Depotneuroleptika auf die Hormonsekretion des Hypophysen-Vorderlappens. Nervenarzt 50:527–533
PubMed
Google Scholar
Diczfalusy E, Lauritzen C (1961) Östrogene beim Menschen. Springer, Berlin Göttingen Heidelberg
Google Scholar
Diedrich K, Wildt L (1990) Neue Wege in Diagnostik und Therapie der Sterilität. Enke, Stuttgart
Google Scholar
DiPaolo T, Payet P, Labrie F (1981) Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors. Eur J Pharmacol 73:105–106
Article
PubMed
Google Scholar
Dupont A, DiPaolo T, Gagne B, Barden N (1981) Effects of chronic estrogen treatment on dopamine concentrations and turnover in discrete brain nuclei of ovariectomized rats. Neurosci Let 22:69–74
Article
Google Scholar
Endo M, Daiguji M, Asano Y, Yamashita I, Takahashi S (1978) Periodic Psychosis recurring in Association with Menstrual Cycle. J Clin Psychiatry 39:456–466
PubMed
Google Scholar
Ferrier IN, Johnstone EC, Crow TJ, Rinzcon-Rodriguez I (1983) Anterior pituitary hormone secretion in chronic schizophrenics: responses to administration of hypothalamic releasing hormones. Arch Gen Psychiatry 40:755
PubMed
Google Scholar
Foreman MM, Porter JC (1980) Effects of catechol estrogens and catecholamines on hypothalamic and corpus striatal tyrosine hydroxylase activity. J Neurochem 34:1175–1183
PubMed
Google Scholar
Gattaz WF, Behrens S, De Vry J, Häfner H (1991) Östradiol hemmt Dopamin-vermittelte Verhaltensweisen bei Ratten: ein Tiermodell zur Untersuchung der geschlechtsspezifischen Unterschiede bei der Schizophrenie. Fortschr Neurol Psychiatr 1:1–44
Google Scholar
Geller EC (1923) Über Eierstocksfunktion bei Dementia praecox auf Grund anatomischer Untersuchungen. Arch Gynae 120:237
Article
Google Scholar
Glick J, Stewart D (1980) A new drug treatment for premenstrual exacerbation of schizophrenia. Compr Psychiatry 21:281–287
Article
PubMed
Google Scholar
Goldstein MJ, Rodnick FH, Evans JR, May PRA, Steinberg MR (1978) Drugs and family therapy in the aftercare of acute schizophrenics. Arch Gen Psychiatry 35:1169–1177
PubMed
Google Scholar
Gordon JH, Diamond BI (1981) Antagonism of dopamine supersensivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia. Biol Psychiatry 16:365–371
PubMed
Google Scholar
Gordon JH, Borison RL, Diamond BI (1980) Modulation of dopamine receptor sensitivity by estrogen. Biol Psychiatry 15:389–396
PubMed
Google Scholar
Häfner H (1987) Epidemiology of Schizophrenia. In: Häfner H, Gattaz WF, Janzarik W (eds) Search for the causes of schizophrenia, vol I. Springer, Berlin Heidelberg New York
Google Scholar
Häfner H, Riecher A, Maurer K, Löffler W, Munk-Jørgensen P, Strömgren E (1989) How does gender influence age at first hospitalization for schizophrenia? Psychol Med 19:903–918
PubMed
Google Scholar
Häfner H, Behrens S, De Vry J, Gattaz WF, Löffler W, Maurer K, Riecher-Rössler A (1991a) Warum erkranken Frauen später an Schizophrenie? Erhöhung der Vulnerabilitätsschwelle durch Östrogen. Nervenheilk 10:154–163
Google Scholar
Häfner H, Behrens S, De Vry J, Gattaz WF (1991b) An animal model for the effects of estradiol on dopamine-mediated behaviour: implications for sex differences in schizophrenia. Psychiatry Res 38:125–134
Article
PubMed
Google Scholar
Häfner H, Riecher-Rössler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, Fätkenheuer B, Löffler W, Heiden W an der (1991c) Geschlechtsunterschiede bei schizophrenen Erkrankungen. Fortsch Neurol Psychiatr 59:343–360
Google Scholar
Hogarty GE, Goldberg SC, Schooler NR, Ulrich RF (1974) Drug and sociotherapy in the aftercare of schizophrenic patients. Arch Gen Psychiatry 31:603–618
PubMed
Google Scholar
Holsboer F, Benkert O, Demisch L (1983) Changes in MAO activity during estrogen treatment of females with endogenous depression. Mod Probl Pharmacopsychiatry 19:321–326
PubMed
Google Scholar
Hruska RE, Silbergeld EK (1980) Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum. Eur J Pharmacol 61:397–400
Article
PubMed
Google Scholar
Kane JM, Cooper TB, Sachar EJ, Halpern FS, Bailine S (1981) Clozapine: plasma levels and prolactin response. Psychopharmacology 73:184
Article
PubMed
Google Scholar
Kendell RE, Chalmers JC, Platz C (1987) Epidemiology of puerperal psychoses. Br J Psychiatry 150:662–673
PubMed
Google Scholar
Koller WC, Weiner WJ, Klawans HL, Nausieda PA (1980) Influence of female sex hormones on neuroleptic-induced behavioral supersensitivity. Neuropharmacology 19:387–391
Article
PubMed
Google Scholar
Kraepelin E. (1909–1915) Psychiatrie, Bd 1–4. Barth, Leipzig
Google Scholar
Krafft-Ebing G von (1896) Untersuchungen über Irresein zur Zeit der Menstruation: Ein klinischer Beitrag zur Lehre vom periodischen Irresein. Arch Psychiatr 8:65–107
Article
Google Scholar
Kretschmer E (1921) Körperbau und Charakter. Untersuchungen zum Konstitutionsproblem und zur Lehre von den Temperamenten. 25th edition 1967. Springer, Berlin Heidelberg New York
Google Scholar
Lewine RRJ (1988) Gender and Schizophrenia. In: Nashrallah HA (ed) Handbook of schizophrenia, vol 3. Elsevier, New York, pp 121–136
Google Scholar
Lobo RA, Shoupe D, Roy S, Paul W (1984) Central and peripheral metabolites of norepinephrine and dopamine in postmenopausal women. Am J Obstet Gynecol 5:548–552
Google Scholar
Maggi A, Perez J (1985) Minireview: role of female gonodal hormones in the CNS; clinical and experimental aspects. Life Sci 37:893–906
Article
PubMed
Google Scholar
Mall G (1959) Neuere Ergebnisse der Psycho-Endokrinologie. Ärztl Prax XI/40:1357–1360
Google Scholar
Mall G (1960) Diagnostik und Therapie ovarieller Psychosen. Zentralbl Gesamte Neurol Psychiatr 155:250
Google Scholar
Naber D, Ackenheil M, Laakman G, Fischer H, von Werder K (1980) Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics. Pharmakopsychiatry 13:325–330
Google Scholar
Nicoletti F, Ferrara N, Patti F, Viglianesi M, Rampello L, Bianchi A, Reggio A, Scapagnini U (1983) Influence of sex steroids and prolactin on haloperidol-induced catalepsy. Brain Res 279:352–358
Article
PubMed
Google Scholar
Nott PN (1982) Psychiatric illness following childbirth in Southampton: A case register study. Psychological Med 12:557–561
Google Scholar
Prentice DS, Deakin JFW (1992) Role of neuroleptic drugs and organic mechanism in the aetiology of menstrual irregularities in women. Schizophr Res 6(2):114
Article
Google Scholar
Riecher A, Maurer K, Löffler W, Fätkenheuer B, an der Heiden W, Häfner H (1989) Schizophrenia — a Disease of Young Single Males? Eur Arch Psychiatry Neuroll Sci 239:210–212
Article
Google Scholar
Riecher A, Maurer K, Löffler W, Fätkenheuer B, an der Heiden W, Munk-Jørgensen P, Strömgren E, Häfner H (1991) Sex differences in age at onset and course of schizophrenic disorders — a contribution to the understanding of the disease? In: Häfner H, Gattaz WF (eds) Search for the causes of schizophrenia, vol 2. Springer, Berlin Heidelberg New York, pp 14–33
Google Scholar
Riecher-Rössler A, Häfner H, Stummbaum M, Maurer K, Schmidt R (1993) Can estradiol modulate schizophrenic symptomatology? Schizophrenia Bull (in press)
Seeman MV (1981) Gender and the Onset of Schizophrenia: Neurohumoral Influences. Psychiatr J Univ Ottawa 6:136–138
Google Scholar
Seeman MV (1983) Interaction of sex, age, and neuroleptic dose. Compr Psychiatry 24:125–128
Article
PubMed
Google Scholar
Seeman MV, Lang M (1990) The role of estrogens in schizophrenia gender differences. Schizophrenia Bull 16:185–194
PubMed
Google Scholar
Villeneuve A, Cazejust T, Cote M (1980) Estrogens in tardive dyskinesia in male psychiatric patients. Neuropsychobiology 6:145–151
PubMed
Google Scholar
Wieck A (1989) Endocrine aspects of postnatal mental disorders. Baillière's Clinical Obstetrics and Gynaecology 3:857–877
Google Scholar